How close are we to the cost of $1,000 for sequencing a genome; ever closer, like the European Union? This is another good example of innovation and costs bearing down on a designated goal, and charting extrapolative curves for the optimists amongst us. Yet, the questions raised form a small part of that broad criticism directed against Kurzweil. We meet this cost: so what?
"Getting it is one thing, but adequately interpreting the information it provides is another big part of this," Gregersen said. "It's a fun thing to do, and there are ways to do it now in which you can contribute to basic science, such as by taking part in a larger registry." But, he added, "In isolation, this information is not helpful yet."
We are not there yet.
